{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:13:53Z","timestamp":1791101633168,"version":"4.1.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1067\/mjd.2002.120568","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T22:14:26Z","timestamp":1030227266000},"page":"1-26","source":"Crossref","is-referenced-by-count":452,"title":["The immunologic basis for the treatment of psoriasis with new biologic agents"],"prefix":"10.1067","volume":"46","author":[{"given":"James G.","family":"Krueger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.120568_bib1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1346-8138.1999.tb02083.x","article-title":"Current consensus and update on psoriasis therapy: a perspective from the U.S","volume":"26","author":"Koo","year":"1999","journal-title":"J Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0002-9343(99)00284-3","article-title":"Psoriasis: current perspectives with an emphasis on treatment","volume":"107","author":"Linden","year":"1999","journal-title":"Am J Med"},{"key":"10.1067\/mjd.2002.120568_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0190-9622(93)70067-4","article-title":"An approach to the treatment of moderate to severe psoriasis with rotational therapy","volume":"28","author":"Weinstein","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1067\/mjd.2002.120568_bib4","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0190-9622(99)70363-4","article-title":"Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results","volume":"41","author":"Koo","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1067\/mjd.2000.106515","article-title":"Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-TAC antibody to patients with psoriasis","volume":"43","author":"Krueger","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/1523-1747.ep12471216","article-title":"Changes in keratinocyte maturation during wound healing","volume":"89","author":"Mansbridge","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0300-2977(98)00090-4","article-title":"Immunological aspects of psoriasis","volume":"53","author":"de Rie","year":"1998","journal-title":"Neth J Med"},{"key":"10.1067\/mjd.2002.120568_bib8","first-page":"315","article-title":"Pathogenic interations of keratinocytes and T lymphocytes in psoriasis","author":"Krueger","year":"1998"},{"key":"10.1067\/mjd.2002.120568_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00582862","article-title":"The dermal inflammatory reaction in intitial psoriatic lesions","volume":"258","author":"Braun-Falco","year":"1977","journal-title":"Arch Dermatol Res"},{"key":"10.1067\/mjd.2002.120568_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/1523-1747.ep12529841","article-title":"Characterization of mononuclear cell infiltrates in psoriatic lesions","volume":"71","author":"Bjerke","year":"1978","journal-title":"J Invest Dermatol"},{"issue":"Suppl","key":"10.1067\/mjd.2002.120568_bib11","first-page":"21","article-title":"Identification of subpopulation of mononuclear cells in psoriatic lesions","volume":"87","author":"Krogh","year":"1979","journal-title":"Acta Derm Venereol"},{"key":"10.1067\/mjd.2002.120568_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00510050","article-title":"Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies","volume":"275","author":"Bos","year":"1983","journal-title":"Arch Dermatol Res"},{"key":"10.1067\/mjd.2002.120568_bib13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1084\/jem.164.4.1013","article-title":"Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques","volume":"164","author":"Gottlieb","year":"1986","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00424268","article-title":"Predominance of \u201cmemory\u201d T cells (CD4+, CDw29+) over \u201cnaive\u201d T cells (CD4+, CD45R+) in both normal and diseased skin","volume":"281","author":"Bos","year":"1989","journal-title":"Arch Dermatol Res"},{"key":"10.1067\/mjd.2002.120568_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0560.1998.tb01694.x","article-title":"Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1)+CD8+CD3+ CTLs as determined by phenotypic analysis","volume":"25","author":"Austin","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2002.120568_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/jaut.1999.0343","article-title":"CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry","volume":"14","author":"Ferenczi","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1067\/mjd.2002.120568_bib17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","volume":"113","author":"Austin","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib18","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1073\/pnas.91.20.9282","article-title":"CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and\/or V beta 13.1 genes","volume":"91","author":"Chang","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mjd.2002.120568_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0167-5699(86)90005-8","article-title":"Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes","volume":"7","author":"Valdimarsson","year":"1986","journal-title":"Immunol Today"},{"key":"10.1067\/mjd.2002.120568_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0167-5699(95)80132-4","article-title":"Psoriasis: a T-cell mediated autoimmune disease induced by streptococcal superantigens?","volume":"16","author":"Valdimarsson","year":"1995","journal-title":"Immunol Today"},{"key":"10.1067\/mjd.2002.120568_bib21","first-page":"702","article-title":"The action of topical steroids, dithranol, and PUVA on T lymphocytes and dendritic cells in psoriasis","volume":"111","author":"Baker","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib22","first-page":"526","article-title":"Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment","volume":"61","author":"Baker","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mjd.2002.120568_bib23","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1001\/jama.1986.03380220076026","article-title":"Cyclosporine improves psoriasis in a double-blind study","volume":"256","author":"Ellis","year":"1986","journal-title":"JAMA"},{"key":"10.1067\/mjd.2002.120568_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2133.1988.tb01768.x","article-title":"The pathomechanisms of psoriasis: the skin immune system and cyclosporin","volume":"118","author":"Bos","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib25","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1991.01680070072008","article-title":"Cycloporine in psoriasis treatment: inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha\/epidermal growth factor receptor pathways","volume":"127","author":"Khandke","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1523-1747.ep12468941","article-title":"A potential role for superantigens in the pathogenesis of psoriasis","volume":"100","author":"Leung","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib27","first-page":"317","article-title":"Psoriasiform dermatitis of AIDS [abstract]","volume":"16","author":"McNutt","year":"1989","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2002.120568_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","article-title":"Psoriasis induced by interferon-alpha","volume":"125","author":"Funk","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archderm.1990.01670270083013","article-title":"Psoriasis induced at the injection site of recombinant interferon gamma: results of immunohistologic investigations","volume":"126","author":"Fierlbeck","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archderm.1996.03890280081011","volume":"132","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1067\/mjd.2002.120568_bib32","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI118989","article-title":"Dermal injection of immunocytes induces psoriasis","volume":"98","author":"Wrone-Smith","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2002.120568_bib33","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archderm.135.9.1104","article-title":"The immunologic and genetic basis of psoriasis","volume":"135","author":"Nickoloff","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.189.4.711","article-title":"312-Nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions","volume":"189","author":"Ozawa","year":"1999","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1751-1097.1996.tb05657.x","article-title":"PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in normal and malignant T-lymphocytes","volume":"63","author":"Johnson","year":"1996","journal-title":"Photochem Photobiol"},{"key":"10.1067\/mjd.2002.120568_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/1523-1747.ep12612745","article-title":"Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate","volume":"104","author":"Jeffes","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib37","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archderm.135.12.1495","article-title":"Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis: evidence for selective effects on activated T lymphocytes","volume":"135","author":"Murphy","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0560.1996.tb01431.x","article-title":"Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infilitration in psoriatic plaques by topical calcitriol","volume":"23","author":"Lu","year":"1996","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2002.120568_bib39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4049\/jimmunol.150.3.1105","article-title":"Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition","volume":"150","author":"Picker","year":"1993","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","article-title":"Lymphocyte homing and homeostasis","volume":"272","author":"Butcher","year":"1996","journal-title":"Science"},{"key":"10.1067\/mjd.2002.120568_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1084\/jem.189.1.37","article-title":"L-selectin-mediated leukocyte adhesion in vivo: microvillous distribution determines tethering efficiency, but not rolling velocity","volume":"189","author":"Stein","year":"1999","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib42","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.141.4.1053","article-title":"6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7","volume":"141","author":"Campbell","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1067\/mjd.2002.120568_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1084\/jem.187.2.205","article-title":"Molecular mechanisms of lymphocyte homing to peripheral lymph nodes","volume":"187","author":"Warnock","year":"1998","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1067\/mjd.2002.120568_bib45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.192.5.681","article-title":"Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells","volume":"192","author":"Abrams","year":"2000","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib46","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.192.5.705","article-title":"Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors","volume":"192","author":"Dieu-Nosjean","year":"2000","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1744-313X.1992.tb00047.x","article-title":"Complexity in the major histocompatibility complex","volume":"19","author":"Trowsdale","year":"1992","journal-title":"Eur J Immunogenet"},{"key":"10.1067\/mjd.2002.120568_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1615\/CritRevImmunol.v17.i2.30","article-title":"Lymphocyte activation in health and disease","volume":"17","author":"Berridge","year":"1997","journal-title":"Crit Rev Immunol"},{"key":"10.1067\/mjd.2002.120568_bib49","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.86.4.1333","article-title":"CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines\/cytokines","volume":"86","author":"Thompson","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mjd.2002.120568_bib50","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1128\/MCB.12.10.4357","article-title":"Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28","volume":"12","author":"Fraser","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1067\/mjd.2002.120568_bib51","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"10.1067\/mjd.2002.120568_bib52","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1126\/science.7694362","article-title":"Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice","volume":"262","author":"Freeman","year":"1993","journal-title":"Science"},{"key":"10.1067\/mjd.2002.120568_bib53","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1182\/blood.V83.9.2580.2580","article-title":"T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28","volume":"83","author":"Nickoloff","year":"1994","journal-title":"Blood"},{"key":"10.1067\/mjd.2002.120568_bib54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.1994.tb00845.x","article-title":"The role of CD40 and its ligand in the regulation of the immune response","volume":"138","author":"Hollenbaugh","year":"1994","journal-title":"Immunol Rev"},{"key":"10.1067\/mjd.2002.120568_bib55","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1182\/blood.V87.11.4520.bloodjournal87114520","article-title":"Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate","volume":"87","author":"Szabolcs","year":"1996","journal-title":"Blood"},{"key":"10.1067\/mjd.2002.120568_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-1759(97)00119-1","article-title":"Generation of monocyte-derived dendritic cells from precursors in rhesus macaque blood","volume":"207","author":"O'Doherty","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1067\/mjd.2002.120568_bib57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation","volume":"184","author":"Cella","year":"1996","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib58","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/eji.1830260732","article-title":"Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production","volume":"26","author":"Peng","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib59","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.186.12.2075","article-title":"TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor","volume":"186","author":"Wong","year":"1997","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1067\/mjd.2002.120568_bib61","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"key":"10.1067\/mjd.2002.120568_bib62","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/1523-1747.ep12381958","article-title":"Th1-Th2 paradigm: insights from leprosy","volume":"102","author":"Modlin","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib63","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.4049\/jimmunol.152.7.3410","article-title":"Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation: keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells","volume":"152","author":"Ullrich","year":"1994","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00302667","article-title":"Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibits TNF alpha's effect on rheumatoid synovial fibroblasts","volume":"14","author":"Taylor","year":"1994","journal-title":"Rheumatol Int"},{"key":"10.1067\/mjd.2002.120568_bib65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/1523-1747.ep12371752","article-title":"T cells involved in psoriasis vulgaris belong to the Th1 subset","volume":"102","author":"Schlaak","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib66","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4049\/jimmunol.145.7.2087","article-title":"Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset","volume":"145","author":"Simon","year":"1990","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib67","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1084\/jem.171.4.979","article-title":"Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function","volume":"171","author":"Daynes","year":"1990","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib68","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1046\/j.1523-1747.1998.00446.x","article-title":"Expression of interleukin-12 is increased in psoriatic skin","volume":"111","author":"Yawalkar","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib69","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI6910","article-title":"Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions","volume":"104","author":"Trepicchio","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2002.120568_bib70","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/349796a0","article-title":"ELAM-1 is an adhesion molecule for skin-homing T cells","volume":"349","author":"Picker","year":"1991","journal-title":"Nature"},{"key":"10.1067\/mjd.2002.120568_bib71","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1067\/mjd.2002.120568_bib72","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJM199912093412407","article-title":"Inflammatory skin diseases, T cells, and immune surveillance","volume":"341","author":"Robert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.120568_bib73","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/1523-1747.ep12499816","article-title":"Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skin","volume":"98","author":"Groves","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib74","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/23495","article-title":"The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells","volume":"400","author":"Campbell","year":"1999","journal-title":"Nature"},{"key":"10.1067\/mjd.2002.120568_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.v19.i1.10","article-title":"Recent advances in chemokines and chemokine receptors","volume":"19","author":"Zlotnik","year":"1999","journal-title":"Crit Rev Immunol"},{"key":"10.1067\/mjd.2002.120568_bib76","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1067\/mjd.2002.120568_bib77","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.4049\/jimmunol.164.7.3465","article-title":"Cutting Edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK\/ALP\/ILC)","volume":"164","author":"Homey","year":"2000","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib78","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","article-title":"Up-regulation of macrophage inflammatory protein-3a\/CCL20 and CC chemokine receptor 6 in psoriasis","volume":"164","author":"Homey","year":"2000","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/84205","article-title":"Chemokines as regulators of T cell differentiation","volume":"2","author":"Luther","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1067\/mjd.2002.120568_bib80","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI1422","article-title":"The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions","volume":"101","author":"Qin","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2002.120568_bib81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/000155599750011615","article-title":"Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis","volume":"79","author":"Raychaudhuri","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1067\/mjd.2002.120568_bib82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2133.1998.02027.x","article-title":"RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol)","volume":"138","author":"Fukuoka","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib83","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780242","article-title":"Potential role of the chemokine receptors CXCR3, CCR4, and the integrin \u03b1E\u03b27 in the pathogenesis of psoriasis vulgaris","volume":"81","author":"Rottman","year":"2001","journal-title":"Lab Invest"},{"key":"10.1067\/mjd.2002.120568_bib84","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/1523-1747.ep12524814","article-title":"Significance and pathogenesis of basal keratinocyte herniations in psoriasis","volume":"87","author":"Heng","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib85","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/1523-1747.ep12371803","article-title":"Differential expression of GRO-\u03b1 and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo","volume":"107","author":"Gillitzer","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib86","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/1523-1747.ep12312542","article-title":"Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells","volume":"105","author":"Detmar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1747.1998.00262.x","article-title":"Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice","volume":"111","author":"Detmar","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.184.1.1","article-title":"Models of T cell anergy: is there a common molecular mechanism?","volume":"184","author":"Schwartz","year":"1996","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.120568_bib89","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.2814489","article-title":"Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides","volume":"246","author":"Howell","year":"1989","journal-title":"Science"},{"key":"10.1067\/mjd.2002.120568_bib90","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/1529-0131(199811)41:11<1919::AID-ART5>3.0.CO;2-1","article-title":"T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides","volume":"41","author":"Moreland","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2002.120568_bib91","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/archderm.1997.03890420031004","article-title":"Persistence of T-cell clones in psoriatic lesions","volume":"133","author":"Chang","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib92","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00007890-199908270-00020","article-title":"HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro","volume":"68","author":"Cole","year":"1999","journal-title":"Transplantation"},{"key":"10.1067\/mjd.2002.120568_bib93","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00007890-199908270-00018","article-title":"A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees","volume":"68","author":"Hsu","year":"1999","journal-title":"Transplantation"},{"key":"10.1067\/mjd.2002.120568_bib94","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00007890-200104150-00020","article-title":"HuM291 (Nuvion), a humanized Fc receptor-nonbinding antibody against CD3, anergizes peripheral blood T cells as partial agonist of the T cell receptor","volume":"15","author":"Chau","year":"2001","journal-title":"Transplantation"},{"key":"10.1067\/mjd.2002.120568_bib95","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.4049\/jimmunol.166.9.5835","article-title":"Anti-CD2 episilon F(ab\u2032) 2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens","volume":"166","author":"Yu","year":"2001","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib96","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0190-9622(89)80200-2","article-title":"Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment","volume":"20","author":"Weinshenker","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib97","unstructured":"Carpenter PA, Appelbaum F, Deeg MJ, Doney K, Gooley T, Krueger J, et al. A humanized non-FCR-binding anti-CD3 versus-host disease. Blood In press."},{"key":"10.1067\/mjd.2002.120568_bib98","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0896-8411(92)90006-C","article-title":"Anti-CD4 monoclonal antibody therapy in severe psoriasis","volume":"5","author":"Morel","year":"1992","journal-title":"J Autoimmun"},{"key":"10.1067\/mjd.2002.120568_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/jaut.1997.0175","article-title":"Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4","volume":"11","author":"Bachelez","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1067\/mjd.2002.120568_bib100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1067\/mjd.2000.107945","article-title":"Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study","volume":"43","author":"Gottlieb","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib101","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1681\/ASN.V641143","article-title":"T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction","volume":"6","author":"Sayegh","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1067\/mjd.2002.120568_bib102","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1073\/pnas.90.14.6586","article-title":"Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation","volume":"90","author":"Gimmi","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mjd.2002.120568_bib103","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1073\/pnas.88.15.6575","article-title":"B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2","volume":"88","author":"Gimmi","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mjd.2002.120568_bib104","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0167-5699(94)90190-2","article-title":"Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes","volume":"15","author":"Nickoloff","year":"1994","journal-title":"Immunol Today"},{"key":"10.1067\/mjd.2002.120568_bib105","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.7520604","article-title":"Treatment of murine lupus with CTLA4Ig","volume":"265","author":"Finck","year":"1994","journal-title":"Science"},{"key":"10.1067\/mjd.2002.120568_bib106","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood.V83.12.3815.3815","article-title":"In vivo blockade of CD28\/CTLA4:B7\/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice","volume":"83","author":"Blazar","year":"1994","journal-title":"Blood"},{"key":"10.1067\/mjd.2002.120568_bib107","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.154.3.1481","article-title":"Role of B7:CD28\/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis","volume":"154","author":"Perrin","year":"1995","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib108","first-page":"3151","article-title":"Tolerance induction by soluble CTLA4 in a mouse skin transplant model","volume":"26","author":"Tepper","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1067\/mjd.2002.120568_bib109","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2002.120568_bib110","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1128\/MCB.7.12.4472","article-title":"T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression","volume":"7","author":"June","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1067\/mjd.2002.120568_bib111","first-page":"840","article-title":"Results of a single-dose, dose-escalating trial of an anti-B7.1 monoclonal antibody (IDEC-114) in patients with psoriasis","volume":"114","author":"Gottlieb","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib112","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.154.6.2668","article-title":"Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10: differential modulation of B7-1 (CD80) and B7-2 (CD86) expression","volume":"154","author":"Mitra","year":"1995","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib113","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archderm.135.2.187","article-title":"Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial","volume":"135","author":"Asadullah","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib114","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":"Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature"},{"key":"10.1067\/mjd.2002.120568_bib115","doi-asserted-by":"crossref","first-page":"13967","DOI":"10.1073\/pnas.93.24.13967","article-title":"Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection","volume":"93","author":"Hancock","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mjd.2002.120568_bib116","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/00007890-199911270-00026","article-title":"Selective deletion of antigen-specific, activated T cells by a humanized MAB to CD2 (MEDI-507) is mediated by NK cells","volume":"68","author":"Branco","year":"1999","journal-title":"Transplantation"},{"key":"10.1067\/mjd.2002.120568_bib117","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.120568_bib118","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3181\/00379727-206-43737","article-title":"Regulation of the human interleukin-2\/interleukin-2 receptor system: a role for immunosuppression","volume":"206","author":"Kaempfer","year":"1994","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1067\/mjd.2002.120568_bib119","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","article-title":"Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation","volume":"338","author":"Vincenti","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.120568_bib120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2230.2000.00612.x","article-title":"Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody","volume":"25","author":"Owen","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib121","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archderm.136.5.675","article-title":"Treatment of severe psoriasis with anti-CD25 monoclonal antibodies","volume":"136","author":"Mrowietz","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60386-7","article-title":"Biology of the interleukin-2 receptor","volume":"70","author":"Nelson","year":"1998","journal-title":"Adv Immunol"},{"key":"10.1067\/mjd.2002.120568_bib123","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(98)70590-0","article-title":"Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial","volume":"38","author":"Bagel","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib124","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI1476","article-title":"IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach","volume":"101","author":"Asadullah","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2002.120568_bib125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1523-1747.2001.01248.x","article-title":"Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8\/CXCR2 pathway and normalization of keratinocyte maturation","volume":"116","author":"Reich","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib126","first-page":"465","article-title":"Interleukin 4-induced immune deviation as therapy for psoriasis [abstract]","volume":"117","author":"Ghoreschi","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib127","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/sj.tpj.6500067","article-title":"Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression in profiling","volume":"1","author":"Oestreicher","year":"2001","journal-title":"The Pharmacogenomics J"},{"key":"10.1067\/mjd.2002.120568_bib128","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120568_bib129","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120568_bib130","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1016\/S0041-1345(98)01365-7","article-title":"Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases","volume":"30","author":"Feldman","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1067\/mjd.2002.120568_bib131","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1067\/mjd.2000.105948","article-title":"Treatment with anti-tumor necrosis factor a (TNF-\u03b1) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions","volume":"42","author":"Oh","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib132","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trial","volume":"357","author":"Chaudhari","year":"2001","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120568_bib133","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120568_bib134","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2133.2001.04089.x","article-title":"Treatment of psoriatic arthritis with antitumor necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate","volume":"144","author":"Ogilvie","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib135","first-page":"989","article-title":"Clinical trials of a fully human anti-IL8 antibody for the treatment of psoriasis [abstract]","volume":"141","author":"Lohner","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib136","doi-asserted-by":"crossref","unstructured":"Gottlieb AB, Krueger JG, Wittkowski K, Dedrick R, Walicke PA, Garovoy M. Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treament with multiple doses of efalizumab, an anti-CD11a antibody. Arch Dermatol In press.","DOI":"10.1001\/archderm.138.5.591"},{"key":"10.1067\/mjd.2002.120568_bib137","first-page":"465","article-title":"Therapeutic CD11a ligation tranmodulates surface expression of \u03b21 and \u03b22 integrins on T-lymphocytes [abstract]","volume":"117","author":"Kagen","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib138","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0190-9622(89)70083-9","article-title":"T lymphocytes and monocytes bind to keratinocytes in frozen sections of biopsy specimens of normal skin treated with gamma interferon","volume":"20","author":"Nickoloff","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib139","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4049\/jimmunol.131.2.611","article-title":"The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions","volume":"131","author":"Krensky","year":"1983","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2002.120568_bib140","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1067\/mjd.2001.117850","article-title":"The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody","volume":"45","author":"Papp","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib141","first-page":"988","article-title":"Anti-E-selection in the treatment of psoriasis","volume":"141","author":"Bhushan","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.120568_bib142","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.RES.86.2.166","article-title":"Antisense intercellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure","volume":"86","author":"Toda","year":"2000","journal-title":"Circ Res"},{"key":"10.1067\/mjd.2002.120568_bib143","first-page":"480","article-title":"Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity","volume":"292","author":"Klimuk","year":"2000","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202841925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202841925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T14:35:27Z","timestamp":1680532527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202841925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0190962202841925"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.120568","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}